Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 26-Jan-23 7:39 PM View:  | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 24-Jan-23 | Option Exercise | 5,000 | $39.15 | $195,750.00 | 6% 85.11K to 90.11K | |
| 26-Jan-23 7:41 PM View: | Dansey Roger D President, R&D & CMO | Seattle Genetics Inc. (SGEN) | 24-Jan-23 | Option Exercise | 10,000 | $72.64 | $726,400.00 | 10% 97.54K to 107.54K | |
| 26-Jan-23 7:39 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 24-Jan-23 | Planned Option Sale | 5,000 | $135.03 | $675,134.00 | (6%) 90.11K to 85.11K | |
| 26-Jan-23 7:41 PM View: | Dansey Roger D President, R&D & CMO | Seattle Genetics Inc. (SGEN) | 24-Jan-23 | Planned Option Sale | 10,000 | $135.00 | $1,350,000.00 | (9%) 107.54K to 97.54K | |
| 19-Jan-23 7:16 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 17-Jan-23 | Market Sale (Planned) | 578 | $130.71 | $75,548.10 | (< 1%) 85.69K to 85.11K | (11%) |
| 06-Jan-23 7:10 PM View: | Dansey Roger D President R&D & CMO | Seattle Genetics Inc. (SGEN) | 05-Jan-23 | Planned Option Sale | 7,500 | $135.00 | $1,012,500.00 | (7%) 105.04K to 97.54K | |
| 06-Jan-23 7:10 PM View: | Dansey Roger D President R&D & CMO | Seattle Genetics Inc. (SGEN) | 05-Jan-23 | Option Exercise | 7,500 | $72.64 | $544,800.00 | 8% 97.54K to 105.04K | |
| 06-Jan-23 7:08 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 05-Jan-23 | Option Exercise | 4,525 | $39.15 | $177,154.00 | 5% 85.69K to 90.22K | |
| 06-Jan-23 7:08 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 05-Jan-23 | Planned Option Sale | 4,525 | $135.00 | $610,875.00 | (5%) 90.22K to 85.69K | |
| 06-Jan-23 7:10 PM View: | Dansey Roger D President R&D & CMO | Seattle Genetics Inc. (SGEN) | 04-Jan-23 | Option Exercise | 2,500 | $72.64 | $181,600.00 | 3% 97.54K to 100.04K | |
| 06-Jan-23 7:08 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 04-Jan-23 | Option Exercise | 475 | $39.15 | $18,596.20 | < 1% 85.69K to 86.17K | |
| 06-Jan-23 7:08 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 04-Jan-23 | Planned Option Sale | 475 | $135.00 | $64,125.00 | (< 1%) 86.17K to 85.69K | |
| 06-Jan-23 7:10 PM View: | Dansey Roger D President R&D & CMO | Seattle Genetics Inc. (SGEN) | 04-Jan-23 | Planned Option Sale | 2,500 | $135.00 | $337,500.00 | (2%) 100.04K to 97.54K | |
| 21-Dec-22 6:48 PM View: | Romp Charles R EVP, Commercial U.S. | Seattle Genetics Inc. (SGEN) | 20-Dec-22 | Market Sale (Planned) | 1,129 | $127.63 | $144,094.00 | (2%) 59.6K to 58.48K | (14%) |
| 16-Dec-22 7:42 PM View: | Dansey Roger D President, Research and Develo | Seattle Genetics Inc. (SGEN) | 14-Dec-22 | Option Exercise | 10,000 | $77.16 | $771,628.00 | 10% 97.54K to 107.54K | |
| 16-Dec-22 7:42 PM View: | Dansey Roger D President, Research and Develo | Seattle Genetics Inc. (SGEN) | 14-Dec-22 | Planned Option Sale | 10,000 | $135.00 | $1,350,000.00 | (9%) 107.54K to 97.54K | |
| 14-Dec-22 5:49 PM View: | Simonian Nancy A Director | Seattle Genetics Inc. (SGEN) | 12-Dec-22 | Option Exercise | 8,750 | $36.70 | $321,125.00 | 16% 54.0K to 62.75K | |
| 18-Nov-22 7:53 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 17-Nov-22 | Option Sale | 8,333 | $131.05 | $1,092,060.00 | (9%) 94.02K to 85.69K | |
| 18-Nov-22 7:53 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 17-Nov-22 | Option Exercise | 8,333 | $34.20 | $284,989.00 | 10% 85.69K to 94.02K | |
| 16-Nov-22 6:22 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 14-Nov-22 | Option Exercise | 1,301 | $76.86 | $99,994.90 | 2% 84.39K to 85.69K | |
| 15-Nov-22 5:46 PM View: | Gryska David W Director | Seattle Genetics Inc. (SGEN) | 11-Nov-22 | Market Sale | 7,500 | $129.10 | $968,220.00 | (16%) 47.75K to 40.25K | (12%) |
| 14-Nov-22 5:45 PM View: | Epstein David R Chief Executive Officer Director | Seattle Genetics Inc. (SGEN) | 09-Nov-22 | Grant | 107,389 | -- | -- | 100% 0 to 107.39K | |
| 14-Nov-22 6:24 PM View: | Swain Sandra M Director | Seattle Genetics Inc. (SGEN) | 09-Nov-22 | Grant | 778 | -- | -- | 100% 0 to 0.78K | |
| 19-Oct-22 7:17 PM View: | Dansey Roger D Interim CEO & CMO | Seattle Genetics Inc. (SGEN) | 17-Oct-22 | Planned Option Sale | 10,000 | $135.00 | $1,350,000.00 | (9%) 107.54K to 97.54K | |
| 19-Oct-22 7:17 PM View: | Dansey Roger D Interim CEO & CMO | Seattle Genetics Inc. (SGEN) | 17-Oct-22 | Option Exercise | 10,000 | $74.54 | $745,421.00 | 10% 97.54K to 107.54K | |
| 01-Sep-22 6:09 PM View: | Simpson Todd E Chief Financial Officer | Seattle Genetics Inc. (SGEN) | 31-Aug-22 | Private Sale (Planned) | 4,186 | $154.41 | $646,379.00 | (3%) 141.37K to 137.19K | |
| 01-Sep-22 6:03 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 31-Aug-22 | Private Sale (Planned) | 3,648 | $154.41 | $563,304.00 | (4%) 88.04K to 84.39K | |
| 01-Sep-22 6:06 PM View: | Romp Charles R EVP, Commercial | Seattle Genetics Inc. (SGEN) | 31-Aug-22 | Private Sale (Planned) | 1,133 | $154.41 | $174,952.00 | (2%) 60.74K to 59.6K | |
| 01-Sep-22 6:03 PM View: | Dansey Roger D Interim CEO & CMO | Seattle Genetics Inc. (SGEN) | 31-Aug-22 | Private Sale (Planned) | 5,019 | $154.41 | $775,006.00 | (5%) 102.56K to 97.54K | |
| 01-Sep-22 6:07 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 31-Aug-22 | Private Sale (Planned) | 3,584 | $154.41 | $553,422.00 | (2%) 190.24K to 186.65K | |
| 17-Aug-22 9:12 PM View: | Dansey Roger D Interim CEO & CMO | Seattle Genetics Inc. (SGEN) | 16-Aug-22 | Sale (Planned) | 4,254 | $170.21 | $724,095.00 | (4%) 106.81K to 102.56K | |
| 17-Aug-22 9:13 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 16-Aug-22 | Sale (Planned) | 1,527 | $170.21 | $259,918.00 | (< 1%) 191.76K to 190.24K | |
| 17-Aug-22 9:19 PM View: | Simpson Todd E Chief Financial Officer | Seattle Genetics Inc. (SGEN) | 16-Aug-22 | Sale (Planned) | 1,967 | $170.21 | $334,813.00 | (1%) 143.34K to 141.37K | |
| 17-Aug-22 9:14 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 16-Aug-22 | Sale (Planned) | 1,639 | $170.21 | $278,983.00 | (2%) 89.68K to 88.04K | |
| 17-Aug-22 9:16 PM View: | Romp Charles R EVP, Commercial | Seattle Genetics Inc. (SGEN) | 16-Aug-22 | Sale (Planned) | 1,765 | $170.21 | $300,430.00 | (3%) 62.5K to 60.74K | |
| 17-Aug-22 9:13 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 15-Aug-22 | Grant | 12,014 | -- | -- | 7% 179.75K to 191.76K | |
| 17-Aug-22 9:19 PM View: | Simpson Todd E Chief Financial Officer | Seattle Genetics Inc. (SGEN) | 15-Aug-22 | Grant | 15,447 | -- | -- | 12% 127.89K to 143.34K | |
| 17-Aug-22 9:14 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 15-Aug-22 | Grant | 13,731 | -- | -- | 18% 75.95K to 89.68K | |
| 17-Aug-22 9:16 PM View: | Romp Charles R EVP, Commercial | Seattle Genetics Inc. (SGEN) | 15-Aug-22 | Grant | 13,731 | -- | -- | 28% 48.77K to 62.5K | |
| 17-Aug-22 9:12 PM View: | Dansey Roger D Interim CEO & CMO | Seattle Genetics Inc. (SGEN) | 15-Aug-22 | Grant | 44,625 | -- | -- | 72% 62.19K to 106.81K | |
| 07-Jul-22 6:50 PM View: | Romp Charles R EVP, Commercial | Seattle Genetics Inc. (SGEN) | 05-Jul-22 | Private Sale (Planned) | 712 | $179.46 | $127,776.00 | (1%) 49.48K to 48.77K | |
| 30-Jun-22 6:02 PM View: | Dansey Roger D Chief Medical Officer | Seattle Genetics Inc. (SGEN) | 28-Jun-22 | Sale (Planned) | 14,891 | $180.00 | $2,680,380.00 | (19%) 76.97K to 62.08K | |
| 30-Jun-22 6:02 PM View: | Dansey Roger D Chief Medical Officer | Seattle Genetics Inc. (SGEN) | 28-Jun-22 | Planned Option Sale | 19,744 | $180.00 | $3,553,920.00 | (20%) 96.72K to 76.97K | |
| 30-Jun-22 6:02 PM View: | Dansey Roger D Chief Medical Officer | Seattle Genetics Inc. (SGEN) | 28-Jun-22 | Option Exercise | 19,744 | $65.11 | $1,285,530.00 | 26% 76.97K to 96.72K | |
| 22-Jun-22 7:03 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 17-Jun-22 | Option Exercise | 1,134 | $41.04 | $46,539.40 | < 1% 179.67K to 180.8K | |
| 22-Jun-22 7:03 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 17-Jun-22 | Planned Option Sale | 1,134 | $160.00 | $181,440.00 | (< 1%) 180.8K to 179.67K | |
| 26-May-22 6:07 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 24-May-22 | Option Exercise | 10,866 | $26.10 | $283,603.00 | 6% 179.67K to 190.53K | |
| 26-May-22 6:07 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 24-May-22 | Planned Option Sale | 10,866 | $136.79 | $1,486,380.00 | (6%) 190.53K to 179.67K | |
| 18-May-22 7:34 PM View: | Romp Charles R EVP, Commercial | Seattle Genetics Inc. (SGEN) | 16-May-22 | Market Sale (Planned) | 333 | $134.21 | $44,690.80 | (< 1%) 49.82K to 49.48K | (8%) |
| 17-May-22 7:32 PM View: | Love Ted W Director | Seattle Genetics Inc. (SGEN) | 13-May-22 | Grant | 1,503 | -- | -- | 47% 3.2K to 4.7K |
